Mirati - oncology?





do you know oncology? Slightly lower dose with sustained treatment exposure would drive better efficacy. Mirati is far from being done.


Clearly I know a lot more about oncology, data and lung cancer than you, as that is not what the data bares out. Keep drinking the Kool-Aid if that’s what gets you through your day. I pray that you are not on our marketing team with nonsensical comments like that…amateur spin for sure.
 




A lot of purple kool aid drinking going on.

Clearly I know a lot more about oncology, data and lung cancer than you, as that is not what the data bares out. Keep drinking the Kool-Aid if that’s what gets you through your day. I pray that you are not on our marketing team with nonsensical comments like that…amateur spin for sure.
 
























Sotorasib is so good that it’s results in CRC and PANC are half as good as those for Adagrasib. All will be revealed in the phase III lung studies. I bought Mirati stock cheap a month ago - Already doing good. I agree though, the word on street is that “the leadership” at Mirati is absolutely soulless selfish, and not strategic. Likely to be bought out before long.
 




Sotorasib is so good that it’s results in CRC and PANC are half as good as those for Adagrasib. All will be revealed in the phase III lung studies. I bought Mirati stock cheap a month ago - Already doing good. I agree though, the word on street is that “the leadership” at Mirati is absolutely soulless selfish, and not strategic. Likely to be bought out before long.

You’re dreaming.
 




















Better than Amgens? Not from what I read as an outside investor. And by the way, Amgen will have Mirati contracted out to Siberia by the time Mirati’s therapy gets approved.